Loading…
Loading…
Waters Corp
NYSE · Stock Profile · Market Cap $17.57B
Current Price
$295.05
-0.65%GoodMoat Value
$243.88
17.3% overvaluedA large-cap company with a $17.6B market cap.
Forward estimates use 50.0% FCF growth (CAGR)
Net Debt: 903M
709M
FY24
740M
FY24
3.0B
FY24
662M
FY25
771M
FY25
800M
FY25
3.2B
FY25
143M
FY24
162M
FY24
638M
FY24
121M
FY25
147M
FY25
149M
FY25
643M
FY25
Waters Corporation is a global leader in life sciences and diagnostics, dedicated to accelerating the benefits of pioneering science through analytical technologies, informatics, and service. With a focus on regulated, high-volume testing environments, our innovative portfolio harnesses deep scientific expertise across chemistry, physics, and biology. We collaborate with customers around the world to advance the release of effective, high-quality medicines, ensure the safety of food and water, and drive better patient outcomes by detecting diseases earlier, managing routine infections, and combating antibiotic resistance. Through a shared culture of relentless innovation, our passionate team of approximately 16,000 colleagues turn scientific challenges into breakthroughs that improve lives worldwide.
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
NYSE
Country
Massachusetts, USA
Price sits at 13% of its 52-week range.
Blended fair value estimate based on DCF, Graham Number, and earnings-based models.
Run a full DCF analysis with customizable assumptions
Open DCF Calculator →Graham Number, PEG-based, and Earnings-based models
View Fair Value →This stock does not currently pay a dividend.
Waters Corporation is a global leader in life sciences and diagnostics, dedicated to accelerating the benefits of pioneering science through analytical technologies, informatics, and service. With a focus on regulated, high-volume testing environments, our innovative portfolio harnesses deep scientific expertise across chemistry, physics, and biology. We collaborate with customers around the world to advance the release of effective, high-quality medicines, ensure the safety of food and water, and drive better patient outcomes by detecting diseases earlier, managing routine infections, and combating antibiotic resistance. Through a shared culture of relentless innovation, our passionate team of approximately 16,000 colleagues turn scientific challenges into breakthroughs that improve lives worldwide.
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
NYSE
Country
Massachusetts, USA